SCHEMBL15859413

SCHEMBL15859413

CC(C)(C)C[C@H](NC(=O)O)C(=O)NC1(C(=O)C(N)=O)CC(F)C1

nearest known ligand 0.42

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CTSS P25774 1/20 0.42
CTSL P07711 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15859414 1.00 CTSS (0.42) CTSSCTSL
SCHEMBL15064330 0.92 CTSS (0.40) CTSS
SCHEMBL12070307 0.86 HDAC4 (0.41) CTSSCTSL
SCHEMBL15859407 0.80 CTSL (0.30) CTSL
SCHEMBL15859406 0.80 CTSL (0.30) CTSL
SCHEMBL15064327 0.79 CTSS (0.34) CTSS
SCHEMBL15086641 0.75 HDAC4 (0.41) CTSSCTSL
SCHEMBL15064628 0.72
SCHEMBL12069219 0.69 CTSS (0.55) CTSS
SCHEMBL28364368 0.67 GRN (0.39) CTSSCTSL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2582660-B1 NEW CATHEPSIN S PROTEASE INHIBITORS, USEFUL IN THE TREATMENT OF E.G. AUTOIMMUNE DISORDERS, ALLERGY AND CHRONIC PAIN CONDITIONS MEDIVIR UK LTD (GB) 2015-07-22 EP disclosed
EP-2752404-A1 Cysteine protease inhibitors Medivir UK Ltd (GB) 2014-07-09 EP disclosed